Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

Seger, Christoph;Shipkova, Maria;Christians, Uwe;Billaud, Elaine M;Wallemacq, Pierre;et.al.
(2016) Therapeutic Drug Monitoring — Vol. 38, n° 2, p. 170-189 (2016)

Files

No attached file found for this publication.

Details

Authors
  • Seger, Christoph
    Author
  • Shipkova, Maria
    Author
  • Christians, Uwe
    Author
  • Billaud, Elaine M
    Author
  • Wallemacq, PierreUCLouvain
    Author
Show more
Abstract
Monitoring immunosuppressive drugs (ISDs) in blood or plasma is still a key therapeutic drug monitoring (TDM) application in clinical settings. Narrow target ranges and severe side effects at drug underexposure or overexposure make accurate and precise measurements a must. This overview prepared by the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology is intended to serve as a summary and guidance document describing the current state-of-the-art in the TDM of ISDs.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Seger, C., Shipkova, M., Christians, U., Billaud, E. M., Wang, P., Holt, D. W., Brunet, M., Kunicki, P. K., Pawiński, T., Langman, L. J., Marquet, P., Oellerich, M., Wieland, E., & Wallemacq, P. (2016). Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee. Therapeutic Drug Monitoring, 38(2), 170-189. https://doi.org/10.1097/FTD.0000000000000269 (Original work published 2016)